| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Immunology |
and CXCR3 LigandsDivisions of 1 Innate Immunity and 2 Immunogenetics, German Cancer Research Center, Heidelberg, Germany
Requests for reprints: Adelheid Cerwenka, Division of Innate Immunity, German Cancer Research Center, Heidelberg, 69120, Germany. Phone: 49-0-6221-424480; Fax: 49-0-6221-423759; E-mail: a.cerwenka{at}dkfz-heidelberg.de.
Key Words: NK cells tumor immunity IFN-
CXCR3 migration
Several studies have correlated high numbers of tumor-infiltrating natural killer (NK) cells with a good prognosis for cancer patients. Our study aimed at identifying factors controlling intratumoral NK cell accumulation in s.c. injected NK cell sensitive tumor models and at studying their effect on survival time of recipient mice. We observed that fewer NK cells infiltrated the tumors in IFN-
receptor knockout (IFN-
R–/–) mice compared with wild-type controls that correlated with decreased survival rate. Exogenous application of IFN-
in the tumor augmented levels of ligands of the chemokine receptor CXCR3, increased NK cell accumulation, and prolonged survival. Furthermore, our data show that CD27high NK cells, which under steady-state conditions express CXCR3, preferentially accumulated in the tumor tissue. Accordingly, significantly lower numbers of tumor-infiltrating NK cells were detected in CXCR3–/– mice, and the capacity of adoptively transferred CXCR3–/– NK cells to accumulate in the tumor was severely impaired. Finally, exogenous application of the CXCR3 ligand CXCL10 in the tumor or ectopic expression of CXCL10 by tumor cells increased the numbers of NK cells in the tumors and prolonged NK cell–dependent survival. Our results identify IFN-
and the expression of CXCR3 on NK cells as prerequisites for NK cell infiltration into tumors. Exploiting strategies to augment NK cell accumulation in the tumor might lead to the development of effective antitumor therapies. [Cancer Res 2008;68(20):8437–45]
This article has been cited by other articles:
![]() |
R. Starr, M. Fuchsberger, L. S. Lau, A. P. Uldrich, A. Goradia, T. A. Willson, A. M. Verhagen, W. S. Alexander, and M. J. Smyth SOCS-1 Binding to Tyrosine 441 of IFN-{gamma} Receptor Subunit 1 Contributes to the Attenuation of IFN-{gamma} Signaling In Vivo J. Immunol., October 1, 2009; 183(7): 4537 - 4544. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saudemont, F. Garcon, H. Yadi, M. Roche-Molina, N. Kim, A. Segonds-Pichon, A. Martin-Fontecha, K. Okkenhaug, and F. Colucci p110{gamma} and p110{delta} isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease PNAS, April 7, 2009; 106(14): 5795 - 5800. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |